Danielle Marjoram

  • Citations Per Year
Learn More
Although the prevention of hemolytic disease of the fetus and newborn is highly effective using polyclonal anti-D, a recombinant alternative is long overdue. Unfortunately, anti-D monoclonal antibodies have been, at best, disappointing. To determine the primary attribute defining an optimal antibody, we assessed suppression of murine red blood cell (RBC)(More)
PURPOSE OF REVIEW This review aims to highlight recent advances in our understanding of how anti-red blood cell (RBC) antibodies prevent erythrocyte immunization with an emphasis on new murine models. RECENT FINDINGS New murine models with clinically relevant human erythrocyte antigens have been used to understand the alloimmunization process and its(More)
  • 1